516
Views
8
CrossRef citations to date
0
Altmetric
Research Article

A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma

, , , &
Pages 1299-1305 | Received 12 Sep 2011, Accepted 10 Dec 2011, Published online: 31 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Enrico Derenzini, Pier Luigi Zinzani & Bruce D. Cheson. (2014) Bendamustine: role and evidence in lymphoma therapy, an overview. Leukemia & Lymphoma 55:7, pages 1471-1478.
Read now
Karem Humala & Anas Younes. (2013) Current and emerging new treatment strategies for mantle cell lymphoma. Leukemia & Lymphoma 54:5, pages 912-921.
Read now
Julie E. Chang & Brad S. Kahl. (2012) Bendamustine: more ammunition in the battle against mantle cell lymphoma. Leukemia & Lymphoma 53:7, pages 1249-1250.
Read now

Articles from other publishers (5)

Shaum M. Kabadi, Aimee Near, Keiko Wada & Chakkarin Burudpakdee. (2019) Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States. Cancer Medicine 8:17, pages 7174-7185.
Crossref
Myron S. Czuczman, A. Goy, D. Lamonica, D. A. Graf, M. C. Munteanu & R. H. van der Jagt. (2015) Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings. Annals of Hematology 94:12, pages 2025-2032.
Crossref
Liang-Tsai Hsiao, Hwei-Fang Tien, Ching-Yuan Kuo, Jin-Hou Wu, Hsin-An Hou, Ming-Chung Wang, Chun-Yu Liu, Po-Min Chen & Tzeon-Jye Chiou. (2015) Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Hematological Oncology 33:4, pages 136-144.
Crossref
Mona Darwish, Mary Bond, Edward Hellriegel, Philmore RobertsonJr.Jr. & James P. Chovan. (2015) Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolites. Cancer Chemotherapy and Pharmacology 75:6, pages 1143-1154.
Crossref
A. García-Noblejas, C. Martínez Chamorro, B. Navarro Matilla, C. Da Silva Rodriguez, T. J. González-Lopez, R. Oña Navarrete, M. J. Ramírez Sánchez, P. Martínez Barranco, J. J. Sánchez Blanco, C. Nicolás, R. Pérez, B. Sánchez González, A. M. Ruedas López, E. Domingo-Domenech, C. Panizo, S. Macia, E. Fernández-Fonseca, J. Cannata-Ortiz & R. Arranz. (2014) Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience. Annals of Hematology 93:9, pages 1551-1558.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.